WO2001020011A1 - Dna construct and its use - Google Patents

Dna construct and its use Download PDF

Info

Publication number
WO2001020011A1
WO2001020011A1 PCT/SE2000/001767 SE0001767W WO0120011A1 WO 2001020011 A1 WO2001020011 A1 WO 2001020011A1 SE 0001767 W SE0001767 W SE 0001767W WO 0120011 A1 WO0120011 A1 WO 0120011A1
Authority
WO
WIPO (PCT)
Prior art keywords
oilseed plant
xanthophyll
dna construct
peptide
nucleotide sequence
Prior art date
Application number
PCT/SE2000/001767
Other languages
French (fr)
Inventor
Anna-Stina HÖGLUND
Kjell STÅLBERG
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to AU76936/00A priority Critical patent/AU7693600A/en
Priority to CA002382444A priority patent/CA2382444A1/en
Priority to JP2001523782A priority patent/JP2003509057A/en
Priority to EP00966616A priority patent/EP1212444A1/en
Publication of WO2001020011A1 publication Critical patent/WO2001020011A1/en
Priority to NO20021305A priority patent/NO20021305L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis

Definitions

  • the present invention relates to a new DNA construct for transformation into oilseed plants.
  • the DNA construct comprises nucleotide sequences encoding peptides with enzyme activities necessary for the high-level production and esterification of keto group-containing xanthophylls in oilseed plants.
  • Carotenoids are produced de novo by plants, fungi, algae and some bacteria. A number of biosynthetic steps are needed for the biological production of the carotenoids. There are two chemically different groups of carotenoids, namely carotenes containing only carbon and hydrogen molecules and xanthophylls containing oxygen in the molecule in addition to carbon and hydrogen.
  • the xanthophylls and particularly astaxanthin (3,3'-dihydroxy- ⁇ - ⁇ -carotene-4,4'- dione), are often colored pigments and are used as such or as anti-oxidants.
  • Carotenes are biological precursors for the production of the oxygen-containing xanthophylls. There are two types of enzymes responsible for the introduction of hydroxy groups and keto groups into the carotenes, namely hydroxylases and ketolases, respectively.
  • keto group-containing xanthophyll astaxanthin which has keto and hydroxy groups, is biosynthetically produced from beta-carotene.
  • Large-scale production of xanthophylles from natural sources is at present performed by AstaCarotene AB, Gustavsberg, Sweden, by cultivation of the alga Haematococcus pluvialis for the production of astaxanthin in esterified form.
  • Oilseed plants have naturally ⁇ -carotene hydroxylases but lack ⁇ -carotene C-4-oxygenase enzymes or ketolases.
  • the present invention provides DNA constructs enabling and promoting production of keto group containing xanthophylls, especially astaxanthin, in oilseed plants, such as rape, sunflower, soybean and mustard.
  • the DNA construct is transformed into the oilseed plant cell for expression of a protein or fused protein which has an enzyme activity enabling keto group insertion into a carotene or hydroxy carotene for the biosynthetic production of a keto group containing xanthophyll, such as cantaxanthin ( ⁇ , ⁇ -carotene-4,4'- dione) and/or astaxanthin.
  • cantaxanthin ⁇ , ⁇ -carotene-4,4'- dione
  • the naturally occurring synthesis of carotenoids involves a number of enzymes, namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta- cyclase, ⁇ -carotene hydroxylase, and ⁇ -carotene C-4-oxygenase.
  • enzymes namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-
  • Genes coding for peptides having these enzymatic activities may be inserted into the DNA construct of the invention, one or several per construct, to promote high-level production in the transgenic oilseed plant. In case only one enzyme coding gene is inserted per plant, two or more plants may be sexually interbred to produce plants containing all the desired enzyme activities.
  • the present invention is directed to a DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region.
  • the DNA construct additionally comprises between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
  • the DNA construct is preferably such that the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production is selected from the group consisting of peptides with 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, ⁇ -carotene hydroxylase, and ⁇ -carotene C-4-oxygenase activity.
  • a nucleotide sequence coding for a peptide with acyl transferase activity may be included in the group.
  • the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated ⁇ -carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
  • the present invention is also directed to a transgenic oilseed plant cell comprising the DNA construct of the invention, and preferably the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
  • the invention is additionally directed to transgenic oilseed plant-produced xanthophyll, e.g. canthaxanthin and astaxanthin.
  • a preferred aspect of the invention is directed to transgenic oilseed plant- produced astaxanthin esters.
  • Fig.l illustrates the nucleotide sequence of the DNA construct comprising the napin promoter, the chloroplast localization signal, the N-terminally truncated ⁇ -carotene C-4-oxygenase gene and the termination sequence, and the deduced amino acid sequences of the transit peptide and the ⁇ -carotene C-4-oxygenase.
  • the invention is illustrated by production of astaxanthin in the seed of oilseed rape.
  • the astaxanthin produced in the seed of the transgenic plant is extracted as part of the extracted oil.
  • transgenic plants are produced having a chimeric DNA construct that is genetically inherited and is able to produce astaxanthin.
  • the nucleotide sequence of the chimeric DNA construct consist of four parts of different genetic origin namely: (1) a promoter, (2) a localization signal, (3) a ⁇ -carotene C-4- oxygenase coding region and (4) a termination sequence.
  • the napin promoter directs transcription to the seed of oilseed rape (Stalberg et al 1996). This promoter was coupled to a localization signal similar but not identical to a transit peptide (TP) of Rbcsla (Krebbers, 1988) that directs the translated product of a fused gene to the chloroplast.
  • TP transit peptide
  • the promoter and the TP sequence were ligated to a part of the coding sequence of a ketolase gene BCK (Kajiwara et al. 1995). This enzyme oxygenates ⁇ -carotene to canthaxanthin, (Fraser et al. 1997).
  • the chimeric DNA construct was then coupled to a suitable termination sequence, e.g. that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end)(Bevan et al. 1983), as illustrated in Fig.l. Cellular storage of Astaxantin
  • an effective esterification of astaxanthin to fatty acids enables storage of the esterified molecules in triacylglycerol containing oleosomes.
  • an acyl transferase can be claimed to be of fundamental importance for the process, as is proteins that can mediate transport of different forms of astaxanthin from the chloroplast to the vesicles.
  • Napin promoter (GeneBank ACCESSION No. J02798) This promoter sequence, a 1145 base pair fragment including the 5' leader sequence has a unique Hindlll site at the 5' end. The 3' end was synthesized with an additionally 6 nucleotide BamHI site.
  • BCK ⁇ -carotene C-4 oxygenase
  • Genebank ACCESSION No. D45881 The BCK fragment was amplified by PCR including a 5' Xbal site and was ligated to the TP already described.
  • the 5' primer (BCK1) used for PCR is homologous to the BCK sequence from nucleotide 264 and the 3' oligonucleotide (Ax40) ends with a stop codon and was synthesized with a Sad restriction site for cloning.
  • the synthesized fragment was fused to the TP as shown in Fig 1.
  • Sad 3 primer AX40 5 'CACCGAGCTCCATGACACTCTTGTGCAGA 3 ' Description of SEQ ID NO:l and SEQ ID NO:2
  • the SEQ ID NO:l is a nucleotide sequence composed of the following features: Nucleotide No.
  • the SEQ ID NO: 2 is a deduced amino acid sequence of the fusion protein of the transit peptide and the peptide with ⁇ -carotene C-4-oxygenase activity.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region is disclosed. The DNA construct may additionally comprise a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant. The peptide with enzyme activity is preferably a peptide with β-carotene C-4-oxygenase activity, e.g. from the alga <aematococcus pluvialis. Comprised by the invention are also a transgenic oilseed plant cell, e.g. of rape, sunflower, soybean or mustard origin, and a transgenic oilseed plant-produced xanthophyll, such as canthaxanthin or astaxanthin, and also astaxanthin esters.

Description

DNA construct and its use.
The present invention relates to a new DNA construct for transformation into oilseed plants. The DNA construct comprises nucleotide sequences encoding peptides with enzyme activities necessary for the high-level production and esterification of keto group-containing xanthophylls in oilseed plants.
Background of the invention Carotenoids are produced de novo by plants, fungi, algae and some bacteria. A number of biosynthetic steps are needed for the biological production of the carotenoids. There are two chemically different groups of carotenoids, namely carotenes containing only carbon and hydrogen molecules and xanthophylls containing oxygen in the molecule in addition to carbon and hydrogen.
The xanthophylls, and particularly astaxanthin (3,3'-dihydroxy-β-β-carotene-4,4'- dione), are often colored pigments and are used as such or as anti-oxidants. Carotenes are biological precursors for the production of the oxygen-containing xanthophylls. There are two types of enzymes responsible for the introduction of hydroxy groups and keto groups into the carotenes, namely hydroxylases and ketolases, respectively.
The keto group-containing xanthophyll astaxanthin, which has keto and hydroxy groups, is biosynthetically produced from beta-carotene. Large-scale production of xanthophylles from natural sources is at present performed by AstaCarotene AB, Gustavsberg, Sweden, by cultivation of the alga Haematococcus pluvialis for the production of astaxanthin in esterified form.
It would be desirable to be able to produce keto group-containing xanthophylls particularly astaxanthin, in oilseed plants. Oilseed plants have naturally β-carotene hydroxylases but lack β-carotene C-4-oxygenase enzymes or ketolases.
Description of the invention The present invention provides DNA constructs enabling and promoting production of keto group containing xanthophylls, especially astaxanthin, in oilseed plants, such as rape, sunflower, soybean and mustard. The DNA construct is transformed into the oilseed plant cell for expression of a protein or fused protein which has an enzyme activity enabling keto group insertion into a carotene or hydroxy carotene for the biosynthetic production of a keto group containing xanthophyll, such as cantaxanthin (β,β-carotene-4,4'- dione) and/or astaxanthin. Use is thus made of the biosynthetic pathway of the oilseed plant to produce carotenoids. The naturally occurring synthesis of carotenoids involves a number of enzymes, namely 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta- cyclase, β-carotene hydroxylase, and β-carotene C-4-oxygenase. Genes coding for peptides having these enzymatic activities may be inserted into the DNA construct of the invention, one or several per construct, to promote high-level production in the transgenic oilseed plant. In case only one enzyme coding gene is inserted per plant, two or more plants may be sexually interbred to produce plants containing all the desired enzyme activities. Thus, the present invention is directed to a DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region. In a preferred embodiment of the invention the DNA construct additionally comprises between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
The DNA construct is preferably such that the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production is selected from the group consisting of peptides with 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, β-carotene hydroxylase, and β-carotene C-4-oxygenase activity. To promote esterification of astaxanthin a nucleotide sequence coding for a peptide with acyl transferase activity may be included in the group.
In a preferred embodiment of the DNA construct according to the invention the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated β-carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
An example of the DNA construct of the invention is presented in the sequence listing as SEQ ID NO:l and in Fig.l. The present invention is also directed to a transgenic oilseed plant cell comprising the DNA construct of the invention, and preferably the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
The invention is additionally directed to transgenic oilseed plant-produced xanthophyll, e.g. canthaxanthin and astaxanthin.
A preferred aspect of the invention is directed to transgenic oilseed plant- produced astaxanthin esters.
The present invention will now be illustrated with reference to the DNA construct disclosed in the sequence listing and in Fig.l, and the following description of embodiments. However, the invention is not limited to these exemplifications.
Short description of the drawings Fig.l illustrates the nucleotide sequence of the DNA construct comprising the napin promoter, the chloroplast localization signal, the N-terminally truncated β-carotene C-4-oxygenase gene and the termination sequence, and the deduced amino acid sequences of the transit peptide and the β-carotene C-4-oxygenase.
Description of embodiments The invention is illustrated by production of astaxanthin in the seed of oilseed rape. The astaxanthin produced in the seed of the transgenic plant is extracted as part of the extracted oil. By use of conventionally used protocols for Agrobacterium tumefaciens mediated transformation such as described by (Hoekema et al.1983, An et al. 1986, Fry et al. 1987, DeBlock et al. 1988, Radke et al.1988, or Moloney et al. 1989) transgenic plants are produced having a chimeric DNA construct that is genetically inherited and is able to produce astaxanthin. The nucleotide sequence of the chimeric DNA construct consist of four parts of different genetic origin namely: (1) a promoter, (2) a localization signal, (3) a β-carotene C-4- oxygenase coding region and (4) a termination sequence.
The napin promoter directs transcription to the seed of oilseed rape (Stalberg et al 1996). This promoter was coupled to a localization signal similar but not identical to a transit peptide (TP) of Rbcsla (Krebbers, 1988) that directs the translated product of a fused gene to the chloroplast. The promoter and the TP sequence were ligated to a part of the coding sequence of a ketolase gene BCK (Kajiwara et al. 1995). This enzyme oxygenates β-carotene to canthaxanthin, (Fraser et al. 1997). The chimeric DNA construct was then coupled to a suitable termination sequence, e.g. that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end)(Bevan et al. 1983), as illustrated in Fig.l. Cellular storage of Astaxantin
The storage of large amounts of free astaxanthin in plants will be difficult due to toxic effects of the molecule as it intercalates in the plant membranes. An effective esterification of astaxanthin to fatty acids enables storage of the esterified molecules in triacylglycerol containing oleosomes. Thus, an acyl transferase can be claimed to be of fundamental importance for the process, as is proteins that can mediate transport of different forms of astaxanthin from the chloroplast to the vesicles.
Sequences and oligonucleotides used in the construction of the DNA construct
1. Napin promoter (GeneBank ACCESSION No. J02798) This promoter sequence, a 1145 base pair fragment including the 5' leader sequence has a unique Hindlll site at the 5' end. The 3' end was synthesized with an additionally 6 nucleotide BamHI site.
2. Transit peptide similar to RBCSla (GeneBank ACCESSION No. XI 3611, X14565)
The transit peptide (TP) was amplified by PCR from -28 to the end of the transit cleavage aa=54/55 site of the Rbcsla gene. The 5' end was synthesized with a BamHI site and similarly the 3' sequence was synthesized with a Xbal site. The two following oligonucleotides were used for the PCR amplification.
BamHI 5 ' primer: TP 1 5 'AGAC GGATCC TCAGTC AC AC AAAGAGT A 3 '
Sad Xbal
3 ' primer: TP2 5 'GTTC GAGCTC TCTAG A CATGCAGTTAACGC 3 '
3. BCK (β-carotene C-4 oxygenase) (Genebank ACCESSION No. D45881) The BCK fragment was amplified by PCR including a 5' Xbal site and was ligated to the TP already described. The 5' primer (BCK1) used for PCR, is homologous to the BCK sequence from nucleotide 264 and the 3' oligonucleotide (Ax40) ends with a stop codon and was synthesized with a Sad restriction site for cloning. The synthesized fragment was fused to the TP as shown in Fig 1. Oligonucleotides used for PCR:
Xbal 5 ' primer: BCK1 5 'ACAG TCTAGA ATGCCATCCGAGTCGTCA 3 '
Sad 3 primer: AX40 5 'CACCGAGCTCCATGACACTCTTGTGCAGA 3 ' Description of SEQ ID NO:l and SEQ ID NO:2
The sequences shown i Fig.1 are the same as the two sequences which are shown in the sequence listing.
The SEQ ID NO:l is a nucleotide sequence composed of the following features: Nucleotide No.
Cloning site Hindlll 1-6
Napin Promoter 1-1145
Cloning site BamHI 1146-1151
Transit peptide leader 1152-1178 Transit peptide coding 1179- 1347
Cloning site Xbal 1348-1353 β-carotene C-4-oxygenase 1354-2217 β-carotene C-4-oxygense 3' untranslated 2218-2266
Cloning site Sad 2267-2272 Nopaline synthetase termination 2273-2536
Cloning site EcoRI 2538-2543
The SEQ ID NO: 2 is a deduced amino acid sequence of the fusion protein of the transit peptide and the peptide with β-carotene C-4-oxygenase activity.
References
An G, Watson BD, Chiang CC (1986), Transformation of tobacco, tomato, potato and Arabidopsis-thaliana using a binary vector system. Plant Physiology 81 (1) 301-305.
Bevan M, Barnes WM and Chilton MD (1983). Structure and transcription of the nopaline synthase gene region of T-DNA. Nucleic Acids Res. 11 (2), 369-385 .
DeBlock M, DeBrouwer D, Tenning P (1989). Transformation of Brassica napus and Brassica oleracea using Agrobacterium tumefaciens and the expression of the BAR and NEO genes in transgenic plants Plant Physiology 91:2, 694-701.
Fraser PD, Miura Y, Misawa N, (1997). In vitro characterization of astaxanthin biosynthetic enzymes. J Biol Chem. Mar 7;272(10):6128-35.
Fry J, Barnason A, and Horsch RB, (1987). Transformation of Brassica napus with Agrobacteriium tumefaciens based vectors. Plant Cell Reports 6:321-325.
Hoekema A, Hirsch PR, Hooykas PJJ Schilperoort, (1983). A binary vector strategy based on separation of vir and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature vol 303, 179-180.
Josefsson LG, Lenman M, Ericson ML and Rask L, (1987). Structure of a gene encoding the 1.7 S storage protein, napin, from Brassica napus. J. Biol. Chem. 262 (25), 12196-12201.
Kajiwara S, KakizonoT, Saito T, Kondo K, OhtaniT, Nishio N, Nagai S and Misawa N. (1995). Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli Plant Mol. Biol. 29 (2), 343-352. Krebbers E, Seurinck J, Herdies L, Cashmore AR and Timko MP, (1988). Four genes in two diverged subfamilies encode the rubulose-1, 5-bisphosphate carboxylase small subunit polypeptides of Arabidopsis thaliana Plant Mol. Biol. 11, 745-759.
Moloney M, Walker JM and Sharma KK, (1989). High efficiency transformation of Brassica napus using Agrobacterium vectors. Plant Cell Reports 8:238-242.
Radke SE, Andrews BM, Moloney MM, Crouch ML, Kridl JC, Knauf VC (1988), Transformation of Brassica napus using Agrobacterium tumefaciens - Developmentally regulated Expression of a reintroduced napin gene. TAG, 75: (5) 685-694 .
Pua E-C, Mehra-Palta A, Nagy F and Chua N-H, (1987). Transgenic plants of Brassica napus. Biotechnology vol 5, 815-817.
Stalberg K, Ellerstόm M, Ezcurra I, Ablov S, Rask L (1996). Disruption of an overlapping E- box/ABRE motif abolished high transcription of the nap A storage-protein promoter in transgenic Brassica napus seeds. Planta 199(4):515-9.

Claims

Claims
1. A DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region.
2. The DNA construct according to claim 1, which between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity additionally comprises a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant.
3. The DNA construct according to claim 1 or 2, wherein the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification is selected from the group consisting of peptides with, 1-D- deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, β-carotene hydroxylase, β-carotene C-4- oxygenase, and acyl transferase activity.
4. The DNA construct according to any one of claims 1 - 3, wherein the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated β-carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
5. The DNA construct according to claim 4, wherein the nucleotide sequence is SEQ ID NO: 1.
6. Transgenic oilseed plant cell comprising the DNA construct of any one of claims 1-5 .
7. Transgenic oilseed plant cell according to claim 6, wherein the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
8. Transgenic oilseed plant-produced xanthophyll.
9. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is canthaxanthin
10. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin.
11. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin esters.
PCT/SE2000/001767 1999-09-17 2000-09-13 Dna construct and its use WO2001020011A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU76936/00A AU7693600A (en) 1999-09-17 2000-09-13 Dna construct and its use
CA002382444A CA2382444A1 (en) 1999-09-17 2000-09-13 Dna construct and its use
JP2001523782A JP2003509057A (en) 1999-09-17 2000-09-13 DNA constructs and uses thereof
EP00966616A EP1212444A1 (en) 1999-09-17 2000-09-13 Dna construct and its use
NO20021305A NO20021305L (en) 1999-09-17 2002-03-15 DNA construction and its use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903336-7 1999-09-17
SE9903336A SE9903336D0 (en) 1999-09-17 1999-09-17 DNA construct and its use

Publications (1)

Publication Number Publication Date
WO2001020011A1 true WO2001020011A1 (en) 2001-03-22

Family

ID=20417035

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2000/001767 WO2001020011A1 (en) 1999-09-17 2000-09-13 Dna construct and its use

Country Status (7)

Country Link
EP (1) EP1212444A1 (en)
JP (1) JP2003509057A (en)
AU (1) AU7693600A (en)
CA (1) CA2382444A1 (en)
NO (1) NO20021305L (en)
SE (1) SE9903336D0 (en)
WO (1) WO2001020011A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101797A1 (en) * 2003-05-15 2004-11-25 Icon Genetics Ag Process of producing a plastid-targeted protein in plant cells
EP1867327A1 (en) 2006-06-16 2007-12-19 Yamaha Hatsudoki Kabushiki Kaisha Astaxanthin and esters thereof for protecting neurocytes and treating Parkinson's disease
US7385123B2 (en) 2002-08-20 2008-06-10 Sungene Gmbh & Co. Kgaa Process for preparing ketocarotenoids in genetically modified organisms
US7541168B2 (en) 2000-07-18 2009-06-02 National Research Council Of Canada Recombinant cyclopentanone monooxygenase [cpmo]
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
US9909130B2 (en) 2005-03-18 2018-03-06 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013149A1 (en) * 1994-10-28 1996-05-09 Amoco Corporation Enhanced carotenoid accumulation in storage organs of genetically engineered plants
WO1998006862A1 (en) * 1996-08-09 1998-02-19 Calgene Llc Methods for producing carotenoid compounds and speciality oils in plant seeds
WO1998018910A1 (en) * 1995-11-24 1998-05-07 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
WO1998037874A1 (en) * 1997-02-27 1998-09-03 Astacarotene Ab Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
WO1999007867A1 (en) * 1997-08-08 1999-02-18 Calgene Llc Methods for producing carotenoid compounds, and speciality oils in plant seeds
WO1999030701A1 (en) * 1997-12-16 1999-06-24 Astacarotene Ab Method of the prophylactic treatment of mastitis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013149A1 (en) * 1994-10-28 1996-05-09 Amoco Corporation Enhanced carotenoid accumulation in storage organs of genetically engineered plants
WO1998018910A1 (en) * 1995-11-24 1998-05-07 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
WO1998006862A1 (en) * 1996-08-09 1998-02-19 Calgene Llc Methods for producing carotenoid compounds and speciality oils in plant seeds
WO1998037874A1 (en) * 1997-02-27 1998-09-03 Astacarotene Ab Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
WO1999007867A1 (en) * 1997-08-08 1999-02-18 Calgene Llc Methods for producing carotenoid compounds, and speciality oils in plant seeds
WO1999030701A1 (en) * 1997-12-16 1999-06-24 Astacarotene Ab Method of the prophylactic treatment of mastitis

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BISWAL B. ET AL.: "Carotenoid catabolism during leaf senescence and its control by light", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B, vol. 30, 1995, pages 3 - 13, XP002908967 *
DATABASE GENBANK [online] 10 September 1999 (1999-09-10), LINDEN H.: "Haematococcus pluvialis carotenoid hydroxylase mRNA", XP002908964, accession no. EMBL Database accession no. AF162276 *
DATABASE GENBANK [online] 18 August 1998 (1998-08-18), SUN Z. ET AL.: "Haematococcus pluvialis isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase (ipiHp1) mRNA", XP002908961, accession no. EMBL Database accession no. AF082325 *
DATABASE GENBANK [online] 18 August 1998 (1998-08-18), SUN Z. ET AL.: "Haematococcus pluvialis isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase (ipiHp2) mRNA", XP002908963, accession no. EMBL Database accession no. AF082326 *
DATABASE GENBANK [online] 2 June 1998 (1998-06-02), HARKER M. ET AL.: "H.pluvialis mRNA for phyteone desaturase", XP002908960, accession no. EMBL Database accession no. X86783 *
DATABASE GENBANK [online] 29 December 1995 (1995-12-29), KAJIWAREA S.: "Haematococcus pluvialis mRNA for beta-carotene ketolase", XP002908959, accession no. EMBL Database accession no. D45881 *
DATABASE GENBANK [online] 30 November 1997 (1997-11-30), HARKER M. ET AL.: "H.pluvialis mRNA for beta-carotene C-4 oxygenase", XP002908958, accession no. EMBL Database accession no. X86782 *
SUSAN BUDAVARI ET AL.: "The Merck Index", 1996, MERCK & CO., INC., NJ, XP002970607 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541168B2 (en) 2000-07-18 2009-06-02 National Research Council Of Canada Recombinant cyclopentanone monooxygenase [cpmo]
US7385123B2 (en) 2002-08-20 2008-06-10 Sungene Gmbh & Co. Kgaa Process for preparing ketocarotenoids in genetically modified organisms
WO2004101797A1 (en) * 2003-05-15 2004-11-25 Icon Genetics Ag Process of producing a plastid-targeted protein in plant cells
AU2004238991B2 (en) * 2003-05-15 2010-04-22 Icon Genetics Gmbh Process of producing a plastid-targeted protein in plant cells
US9909130B2 (en) 2005-03-18 2018-03-06 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi
EP1867327A1 (en) 2006-06-16 2007-12-19 Yamaha Hatsudoki Kabushiki Kaisha Astaxanthin and esters thereof for protecting neurocytes and treating Parkinson's disease
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
US9297031B2 (en) 2006-09-28 2016-03-29 Dsm Ip Assets B.V. Production of carotenoids in oleaginous yeast and fungi
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes

Also Published As

Publication number Publication date
NO20021305D0 (en) 2002-03-15
NO20021305L (en) 2002-05-15
CA2382444A1 (en) 2001-03-22
AU7693600A (en) 2001-04-17
SE9903336D0 (en) 1999-09-17
EP1212444A1 (en) 2002-06-12
JP2003509057A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
US6787683B1 (en) Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
US5618988A (en) Enhanced carotenoid accumulation in storage organs of genetically engineered plants
Ronen et al. Regulation of carotenoid biosynthesis during tomato fruit development: expression of the gene for lycopene epsilon‐cyclase is down‐regulated during ripening and is elevated in the mutant Delta
EP1549133B1 (en) Fatty acid desaturases from fungi
EP1709179B1 (en) Transgenic plants with reduced level of saturated fatty acid and methods for making them
EP0746615B1 (en) Dna constructs, cells and plants derived therefrom
JP2004514401A (en) Transgenic plants containing tocopherol methyltransferase
CA2491234A1 (en) Use of a gene for increasing the oil content in plants
US8557585B2 (en) Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same
US20150322444A1 (en) Enhanced accumulation of carotenoids in plants
EP1212444A1 (en) Dna construct and its use
KR100905219B1 (en) Fusion polynucleotide for biosynthesis of beta-carotene comprising self-cleavage 2A sequence and transformed cell using the same
Karim Zarhloul et al. Breeding high-stearic oilseed rape (Brassica napus) with high-and low-erucic background using optimised promoter-gene constructs
CA2423502A1 (en) Triacylglycerol lipases from arabidopsis thaliana

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2382444

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000966616

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 76936/00

Country of ref document: AU

Ref document number: 10070412

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 523782

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000966616

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000966616

Country of ref document: EP